Platelet Activation and Atherothrombosis
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
This review of the role of platelets in atherothrombosis illuminates the surprisingly numerous activities of these tiny, anucleate cells and stresses their participation in the inflammatory component of atherothrombosis. The information is presented in the context of the prevention of atherothrombosis by antiplatelet agents now in clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many alternate pathways for platelet activation exist that are independent of thromboxane A 2 and thus are not sensitive to the effects of aspirin (192).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [192]
In the citing paper
“Many alternate pathways for platelet activation exist that are independent of thromboxane A2 and thus are not sensitive to the effects of aspirin (157).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [157]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
BORN, G. V. R. (1962) · Nature · doi:10.1038/194927b0 · Cited by 4,294
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2
Dienstl, F., Backer, G. D., Cairns, J., Pedersen, F., Kala, R., Boissel, J., Schroeder, R., Horgan, J., & Tognoni, G. (1988) · The Lancet · Cited by 2,754
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Davies, M. J., & Thomas, A. C. (1985) · Heart · doi:10.1136/hrt.53.4.363 · Cited by 1,985
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Research works printed but not linked: 4
- 10.1172/jci21446 · doi:10.1172/jci21446 · Paper page
- 1988, Lancet, 2, 349
- 10.1172/jci23683 · doi:10.1172/jci23683 · Paper page
- 10.1172/jci20986 · doi:10.1172/jci20986 · Paper page
Cited by
Items 801–900 of 1,002
Adaptive force sonorheometry for assessment of whole blood coagulation
Mauldin, F. W., Viola, F., Hamer, T. C., Ahmed, E. M. S., Crawford, S., Haverstick, D. M., Lawrence, M. B., & Walker, W. F. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.01.018 · Cited by 28
Uçar, F. M., Açar, B., Gül, M., Özeke, Ö., & Aydoğdu, S. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.6.821 · Cited by 25
Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications
Goli, R. R., Contractor, M. M., Nathan, A. S., Tuteja, S., Kobayashi, T., & Giri, J. S. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0698-2 · Cited by 28
The Role of Antiplatelet Therapy in Patients With MINOCA
Ortega‐Paz, L., Galli, M., Capodanno, D., Brugaletta, S., & Angiolillo, D. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.821297 · Cited by 26
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell
Morotti, A., Barale, C., Melchionda, E., & Russo, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911446 · Cited by 26
Ahmadi, J., Hosseini, E., Kargar, F., & Ghasemzadeh, M. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02729-y · Cited by 27
Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling
Jiang, H., Zhang, L., Yang, M., Li, G., Ding, C., Xin, M., Dai, J., Sun, X., Fan, X., Sun, H., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.06.039 · Cited by 25
Nardin, M., Verdoia, M., Cao, D., Nardin, S., Kedhi, E., Galasso, G., Hof, A. W. J. V. ’., Condorelli, G., & Luca, G. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186074 · Cited by 27
Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis
Ye, Y., Yang, L., Leng, M., Wang, Q., Wu, J., Wan, W., Wang, H., Li, L., Peng, Y., Chai, S., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1255069 · Cited by 27
Santilli, F., Pignatelli, P., Violi, F., & Davì, G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0202 · Cited by 29
Self-citationJang, J. Y., Wang, S. B., Min, J. H., Chae, Y. H., Baek, J. Y., Yu, D., & Chang, T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644260 · Cited by 25
Liu, J.-Q., Lee, T.-F., Miedzyblocki, M., Chan, G., Bigam, D. L., & Cheung, P. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.03.047 · Cited by 25
Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome
Yakubov, S. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903223895 · Cited by 25
The Future of Antiplatelet Therapy in Cardiovascular Disease
Patrono, C., & Rocca, B. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-020209-171035 · Cited by 26
Self-citationŁukasik, M., Dworacki, G., Michalak, S., Kufel-Grabowska, J., Golański, J., Watała, C. W., & Kozubski, W. P. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.06.016 · Cited by 25
Lüdicke, F., Magnette, J., Baker, G. S., & Weitkunat, R. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1096303 · Cited by 29
Dimitriu‐Leen, A. C., Scholte, A. J. H. A., van Rosendael, A. R., van den Hoogen, I. J., Kharagjitsingh, A. V., Wolterbeek, R., Knuuti, J. M., Kroft, L. J. M., Delgado, V., Jukema, J. W., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.023 · Cited by 26
Cho, E. H., Bauder, A. R., Centkowski, S., Shammas, R. L., Mundy, L. R., Kovach, S. J., Levin, L. S., & Hollenbeck, S. T. (2016) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000002893 · Cited by 25
Chiang, C.-Y., Chien, C., Qiou, W.-Y., Chang, C. C.-C., Yu, I., Chang, P., & Chien, C. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1672206 · Cited by 25
Lee, S., Koppensteiner, R., Kopp, C. W., & Gremmel, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-54899-0 · Cited by 25
Pepine, C. J. (2010) · Annals of Medicine · doi:10.3109/07853890903260898 · Cited by 25
Haemostasis, blood platelets and coagulation
Eyre, L., & Gamlin, F. (2010) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2010.02.015 · Cited by 25
Fujisue, K., Sugiyama, S., Ono, T., Matsuzawa, Y., Akiyama, E., Sugamura, K., Matsubara, J., Kurokawa, H., Kaikita, K., Iwashita, S., et al. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000278 · Cited by 28
Vorapaxar: A Review of Its Use in the Long-Term Secondary Prevention of Atherothrombotic Events
Frampton, J. E. (2015) · Drugs · doi:10.1007/s40265-015-0387-9 · Cited by 27
Increased Platelet Binding to Circulating Monocytes in Idiopathic Pulmonary Fibrosis
Fahim, A., Crooks, M. G., Morice, A. H., & Hart, S. P. (2014) · Lung · doi:10.1007/s00408-013-9546-5 · Cited by 26
Kalantzi, K. I., Dimitriou, A. A., Goudevenos, J. A., & Tselepis, A. D. (2011) · Platelets · doi:10.3109/09537104.2011.597527 · Cited by 25
Duerschmied, D., Meiner, M., Peter, K., Neudorfer, I., Roming, F., Zirlik, A., Bode, C., von Elverfeldt, D., & Mühlen, C. V. Z. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e31821e62fb · Cited by 24
Platelet Count and Mean Platelet Volume at the Time of and After Acute Myocardial Infarction
Amraotkar, A. R., Song, D. D., Otero, D., Trainor, P. J., Ismail, I., Kothari, V., Singh, A., Moore, J. B., Rai, S. N., & DeFilippis, A. P. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616683804 · Cited by 24
Association Between Arsenic Exposure and Cardiovascular Disease
Kononenko, M., & Frishman, W. H. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000357 · Cited by 24
Hormones, age, and sex affect platelet responsiveness in vitro
Hadley, J. B., Kelher, M. R., Coleman, J. R., Kelly, K. K., Dumont, L. J., Esparza, O., Banerjee, A. M., Cohen, M. J. M., Jones, K. L., & Silliman, C. C. (2022) · Transfusion · doi:10.1111/trf.17054 · Cited by 26
Huseynov, A., Reinhardt, J., Chandra, L., Dürschmied, D., & Langer, H. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076280 · Cited by 26
Impact of Physical Exercise on Platelets: Focus on Its Effects in Metabolic Chronic Diseases
Barale, C., Melchionda, E., Tempesta, G., Morotti, A., & Russo, I. (2023) · Antioxidants · doi:10.3390/antiox12081609 · Cited by 27
Expression of stromal‐cell‐derived factor‐1 (SDF‐1): a predictor of ischaemic stroke?
Wurster, T. H., Stellos, K., Geisler, T., Seizer, P., Andía, M. E., Schuster, A., May, A. E., Melms, A., Gawaz, M., & Bigalke, B. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03527.x · Cited by 26
New Insights into Modulation of Thrombin Formation
Spronk, H. M. H., Borissoff, J. I., & Cate, H. T. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0363-3 · Cited by 25
Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous
Bigalke, B., Stellos, K., Geisler, T., Kremmer, E., Seizer, P., May, A. E., Lindemann, S., & Gawaz, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.12.026 · Cited by 24
Navarrete, A., Casari, C., Legendre, P., Marx, I., Hu, J., Lenting, P. J., Christophe, O. D., & Denis, C. V. (2012) · Blood · doi:10.1182/blood-2012-03-420042 · Cited by 24
Yilmaz, S., Karaca, E. Ö., İpçi, Ş. D., Çakar, G., Kuru, B. E., Küllü, S., & Horwitz, J. (2012) · Platelets · doi:10.3109/09537104.2012.695033 · Cited by 24
Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo
Struthmann, L., Hellwig, N., Pircher, J., Sohn, H.-Y., Buerkle, M. A., Klauß, V., Mannell, H., Pohl, U., & Krötz, F. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03582.x · Cited by 29
Proteomics of blood and derived products: what’s next?
Prudent, M., Tissot, J., & Lion, N. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.58 · Cited by 25
Sira, J., & Eyre, L. (2016) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2015.11.004 · Cited by 32
Giustino, G., Kirtane, A. J., Généreux, P., Baber, U., Witzenbichler, B., Neumann, F., Weisz, G., Maehara, A., Rinaldi, M., Metzger, C., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.03.001 · Cited by 24
Seyed-Mohammadzad, M., Eskandari, R., Rezaei, Y., Khademvatani, K., Mehrpooya, M., Rostamzadeh, A., & Zahedi, A. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5169 · Cited by 25
Li, Y., Nishikawa, T., & Kaneda, Y. (2016) · Scientific Reports · doi:10.1038/srep25077 · Cited by 24
Jin, J., Liu, T., Li, M., Yuan, C., Liu, Y., Tang, J., Feng, Z., Zhou, Y., Yang, F., & Gu, N. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.01.009 · Cited by 25
Santilli, F., Zaccardi, F., Liani, R., Petrucci, G., Simeone, P., Pitocco, D., Tripaldi, R., Rizzi, A., Formoso, G., Pontecorvi, A., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3232 · Cited by 24
Self-citationStaphylococcus aureus α-Toxin Triggers the Synthesis of B-Cell Lymphoma 3 by Human Platelets
Schubert, S., Schwertz, H., Weyrich, A. S., Franks, Z. G., Lindemann, S., Otto, M., Behr, H., Loppnow, H., Schlitt, A., Ruß, M., et al. (2011) · Toxins · doi:10.3390/toxins3020120 · Cited by 24
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress
Ferrante, E., Vazzana, N., Santilli, F., Cicco, M. D., Lauriti, C., Battista, L. D., Ciabattoni, G., Matteo, L. D., & Davı̀, G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.06.009 · Cited by 24
Self-citationZhang, Z., Yang, Y., Hill, M. A., & Wu, J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00433 · Cited by 26
Myocardial Ischemia–Reperfusion Injury—Mechanistic Insights and Novel Therapeutics
Han, D.-Y., Ahn, H., & Park, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052106 · Cited by 26
Immune-mediated and lipid-mediated platelet function in atherosclerosis
Ahmadsei, M., Lievens, D., Weber, C., von Hundelshausen, P., & Gerdes, N. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000212 · Cited by 24
The Operculina macrocarpa (l.) urb. (jalapa) tincture modulates human blood platelet aggregation
Pierdoná, T. M., Lima, N. R., Rodrigues, R. C. M., Teixeira, J. P., Gonçalves, R. P., Fontenele, J. B., Vasconcelos, S. M. M., Viana, G. S. D. B., & Leal, L. K. A. M. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.10.008 · Cited by 23
Diabetes and Vascular Disease: Is It All About Glycemia?
Vecchié, A., Montecucco, F., Carbone, F., Dallegri, F., & Bonaventura, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190830181944 · Cited by 24
The Role of Interleukin-18 in the Development and Progression of Atherosclerosis
Bahrami, A., Sathyapalan, T., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427095830 · Cited by 26
Fabris, E., Korjian, S., Coller, B. S., ten Berg, J. M., Granger, C. B., Gibson, C. M., & Hof, A. W. J. V. ’. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1414-5009 · Cited by 24
Adane, T., Asrie, F., Getaneh, Z., & Getawa, S. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23808 · Cited by 30
Redox Mechanisms of Platelet Activation in Aging
Gu, S. X., & Dayal, S. (2022) · Antioxidants · doi:10.3390/antiox11050995 · Cited by 25
Danquah, C. A., Minkah, P. A. B., Agana, T. A., Moyo, P., Ofori, M., Doe, P., Rali, S., Duah, I. O., Amankwah, K. B., Somuah, S. O., et al. (2022) · Molecules · doi:10.3390/molecules27144475 · Cited by 27
Atherothrombosis and the role of antiplatelet therapy
Steg, P. G., Dorman, S. H., & Amarenco, P. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04277.x · Cited by 27
Topf, F., Schvartz, D., Gaudet, P., Priego‐Capote, F., Zufferey, A., Turck, N., Binz, P., Fontana, P., Wiederkehr, A., Finamore, F., et al. (2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.03.002 · Cited by 24
Gifford, S. C., Spillane, A. M., Vignes, S. M., & Shevkoplyas, S. S. (2014) · Lab on a Chip · doi:10.1039/c4lc00785a · Cited by 23
SCH 530348: A Novel Oral Thrombin Receptor Antagonist
Bonaca, M. P., & Morrow, D. A. (2009) · Future Cardiology · doi:10.2217/fca.09.27 · Cited by 23
Platelet P2Y12 Receptor Inhibition
Vivas, D., & Angiolillo, D. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11537670-000000000-00000 · Cited by 23
Giri, A. K., Khan, N. M., INDICO, Basu, A., Tandon, N., Scaria, V., & Bharadwaj, D. (2014) · Pharmacogenomics · doi:10.2217/pgs.13.241 · Cited by 23
Activity profiling of platelets by chemical proteomics
Wong, J. W. H., McRedmond, J. P., & Cagney, G. (2008) · PROTEOMICS · doi:10.1002/pmic.200800185 · Cited by 23
Postula, M. A., Janicki, P. K., Rosiak, M., Kapłon‐Cieślicka, A., Trzepla, E., Filipiak, K. J., KOSIOR, D. A., Członkowski, A., & Opolski, G. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0823-6 · Cited by 24
Review: Antiplatelet Drugs: What Comes Next?
Kei, A. A., Florentin, M., Mikhailidis, D. P., Elisaf, M., & Liberopoulos, E. N. (2010) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610385222 · Cited by 25
New mechanisms of antiplatelet activity of nifedipine, an L-type calcium channel blocker
Chou, T. (2014) · Biomedicine · doi:10.7603/s40681-014-0024-z · Cited by 24
Jiang, W., Boyle, S. H., Ortel, T. L., Samad, Z. Z., Velazquez, E. J., Harrison, R. W., Wilson, J. L., Kuhn, C. M., Williams, R. B., O’Connor, C. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.12.002 · Cited by 24
Design, Virtual Screening, and Synthesis of Antagonists of αIIbβ3 as Antiplatelet Agents
Полищук, П. Г., Samoylenko, G. V., Khristova, T. M., Krysko, O. L., Кабанова, Т. А., Kabanov, V. M., Kornylov, A. Y., Klimchuk, O., Langer, T., Andronati, S. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00865 · Cited by 24
Panova‐Noeva, M., van der Meijden, P. E. J., & Cate, H. T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010092 · Cited by 23
Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia
Burnett, J. R., & Hooper, A. J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.044 · Cited by 25
Medina, C., Tomaszewski, K. A., Gilmer, J. F., Bazou, D., Santos-Martínez, M. J., & Radomski, M. W. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84305 · Cited by 24
Ulus, T., Isgandarov, K., Yılmaz, A. S., Uysal, S., Vasi, İ., Dural, M., & Mutlu, F. (2018) · Angiology · doi:10.1177/0003319718760916 · Cited by 23
Morphology of Atherosclerotic Lesions
Simionescu, M., & Sima, A. V. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_2 · Cited by 31
Vorapaxar: a novel protease-activated receptor-1 inhibitor
Gurbel, P. A., Jeong, Y., & Tantry, U. S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.606809 · Cited by 22
Guo, M., Fan, S., Chen, Q., Jia, C., Qiu, M., Bu, Y., Tang, W. H., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922868 · Cited by 22
Aragona, F., Arfuso, F., Fazio, F., Caro, S. D., Giudice, E., Monteverde, V. P., Piccione, G. G., & Giannetto, C. (2023) · Animals · doi:10.3390/ani13111865 · Cited by 22
Clopidogrel Use in End‐Stage Kidney Disease
Tanios, B. Y., Itani, H. S., & Zimmerman, D. L. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12338 · Cited by 23
Liu, Y., Yin, H.-J., & Chen, K. (2011) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-011-0814-z · Cited by 22
Antiplatelet therapy and vascular disease: an update
Buch, M. H., Prendergast, B., & Storey, R. F. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710375780 · Cited by 23
Jiang, Z., Wu, H., Duan, Z., Wang, Z., Hu, K., Ye, F., & Zhang, Z. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.03.011 · Cited by 22
Siasos, G., Oikonomou, E. K., Zaromitidou, M., Kioufis, S., Kokkou, E., Mourouzis, K., Vlasis, K. G., Vavuranakis, M., Stone, P. H., Papavassiliou, A. G., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.009 · Cited by 22
Dehghani, M. R., Rezaei, Y., Fakour, S., & Arjmand, N. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.2.229 · Cited by 22
Diallyl Trisulfide Inhibits Platelet Aggregation through the Modification of Sulfhydryl Groups
Hosono, T., Sato, A., Nakaguchi, N., Ozaki‐Masuzawa, Y., & Seki, T. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05557 · Cited by 22
Biomechanics in thrombus formation from direct cellular simulations
Ye, T., Zhang, X., Li, G., & Wang, S. (2020) · Physical review. E · doi:10.1103/physreve.102.042410 · Cited by 22
Simeoni, S., Biselli, R., D’Amelio, R., Rocca, B., Lattanzio, S., Mucci, L., Davì, G., & Patacchioli, F. R. (2011) · Stress · doi:10.3109/10253890.2010.545458 · Cited by 24
Self-citationCardiovascular risk and dietary sugar intake: is the link so sweet?
Mucci, L., Santilli, F., Cuccurullo, C., & Davì, G. (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0606-7 · Cited by 26
Self-citationEffects on platelet function of a direct acting antagonist of coagulation factor Xa
Ringwala, S. M., DiBattiste, P. M., & Schneider, D. J. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0727-5 · Cited by 22
Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
Hoefer, T., Armstrong, P. C. J., Finsterbusch, M., Chan, M. V., Kirkby, N. S., & Warner, T. D. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306219 · Cited by 24
Nardin, M., Verdoia, M., Barbieri, L., Luca, G. D., & on behalf of the Novara Atherosclerosis Study Group (NAS) (2018) · Platelets · doi:10.1080/09537104.2018.1499885 · Cited by 22
Li, M., Ren, R., Wang, K., Wang, S., Chow, A., Yang, A., Lu, Y., & Leo, C. (2025) · Nutrients · doi:10.3390/nu17071122 · Cited by 22
Woo, J. S., Kim, W., Jang, H. H., Kim, J. B., Kim, W.-S., & Kim, K. S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.025 · Cited by 21
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease
Minno, G. D., Spadarella, G., Cafaro, G., Petitto, M., Lupoli, R., Minno, A. D., de Gaetano, G., & Tremoli, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.932618 · Cited by 26
Krychtiuk, K. A., Speidl, W. S., Giannitsis, E., Gigante, B., Gorog, D. A., Jaffe, A. S., Mair, J. M., Möckel, M., Mueller, C. E., Storey, R. F., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaa025 · Cited by 27
Sura, R. S., SUBRAHMANYAM, C., & Rachamalla, S. S. (2022) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2022v14i1.43328 · Cited by 21
Mohammed, A. A. S., Liu, L., Mareai, R. M., Mohammed, A., Yin, G., Singh, S., Xu, Y., Abdu, F. A., & Che, W. (2022) · Mediators of Inflammation · doi:10.1155/2022/5642406 · Cited by 23
Platelet Thrombin Receptor Antagonism With Vorapaxar: Pharmacology and Clinical Trial Development
Franchi, F., Rollini, F., Park, Y., & Angiolillo, D. J. (2015) · Future Cardiology · doi:10.2217/fca.15.50 · Cited by 21
Bon, E. D., Bonanni, G., Saggiorato, G., Bassi, P., & Cella, G. (2010) · Angiology · doi:10.1177/0003319710362977 · Cited by 21
Intake of dissolved organic matter from deep seawater inhibits atherosclerosis progression
Radhakrishnan, G., Yamamoto, M., Maeda, H., Nakagawa, A., KatareGopalrao, R., Okada, H., Nishimori, H., Wariishi, S., Toda, E., Ogawa, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.073 · Cited by 23
Kato, H., Adachi, S., Doi, T., Matsushima‐Nishiwaki, R., Minamitani, C., Akamatsu, S., Enomoto, Y., Tokuda, H., Otsuka, T., Iwama, T., et al. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.003 · Cited by 21
Metadata
- Authors
- Davì, G., & Patrono, C.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- ORCID
- Patrono, Carlo
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-13
- Volume
- 357
- Issue
- 24
- Pages
- 2482-2494
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2058217708
- Cited by
- 2,135
- References
- 113
- Citations by year
- 2026: 59 · 2025: 81 · 2024: 80 · 2023: 84 · 2022: 102 · 2021: 109 · 2020: 111 · 2019: 106 · 2018: 120 · 2017: 128 · 2016: 116 · 2015: 152 · 2014: 151 · 2013: 145 · 2012: 164
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- platelet activation, atherothrombosis, platelets, inflammation, antiplatelet agents
- MeSH terms
- Animals, Blood Platelets, Brain Ischemia, Humans, Thrombosis, Platelet Activation, Reactive Oxygen Species, Inflammation Mediators, Atherosclerosis, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.